source
- HHS permits compounding of six experimental peptides despite FDA scientists' safety concernsHHS issued a temporary policy that lets licensed pharmacies and physicians compound six experimental peptides without risk of federal enforcement. The list includes the injury-recovery duo BPC-157…
- Lilly can’t stop, won’t stop as revenue climbs 39% thanks to GLP-1 bestsellersEli Lilly’s shares rose 4% in early morning trading after reporting revenue of $24.4 billion, well past consensus estimates.